Results 331 to 340 of about 343,340 (395)

Predictive value of tumor-infiltrating lymphocytes combined with tumor-stromal ratio for axillarylymph node metastasis in breast cancer patients - a retrospective cohort study. [PDF]

World J Surg Oncol
Han H, Yin S, He X, Zhou F, He M.
europepmc   +1 more source

The combination of CDX2 expression status and tumor-infiltrating lymphocyte density as a prognostic factor in adjuvant FOLFOX-treated patients with stage III colorectal cancers

Ji-Ae Lee, Hye Eun Park, Hye‐Yeong Jin, Lingyan Jin, Seung Yeon Yoo, Nam-Yun Cho, Jeong Mo Bae, Jung Ho Kim, Gyeong Hoon Kang   +8 more
openalex   +1 more source

Soft‐Drug‐Inspired MnSTF Nano‐Adjuvant for Safe and Synergistic cGAS–STING Activation in Tumor Immunotherapy

Advanced Science, EarlyView.
This study introduces MnSTF, a soft‐drug‐inspired nanoadjuvant that overcomes the systemic toxicity of STING agonists. Through Mn2+ coordination with an ENPP1 inhibitor, it enables safe cGAS‐STING activation, remodels the tumor immune microenvironment, and synergizes with radiotherapy or vaccines to elicit robust antitumor immunity.
Guangfei Sun, Jiancheng Pan, Rui Li, Ruoxi Li, Ziyan Liu, Jinhui Wu, Tingsheng Lin, Yiqiao Hu, Ahu Yuan   +8 more
wiley   +1 more source

Relationship between tumor infiltrating lymphocytes and hormone-sensitive (breast and prostate) cancer survival: cases received at Yaoundé General Hospital (Cameroon) from 2019 to 2023

Stéphane Zingue, Etienne Okobalemba Atenguena, Kevine Ghubap Makamte, Danielle Ingrid Tekam Maliedje, Laure Leka Zingué, Manuella Mayemi, Estelle Alida Ngne Mbopda, Zacharie Sando   +7 more
openalex   +1 more source

Roles of Tumor-Infiltrating Lymphocytes and Antitumor Immune Responses as Predictive and Prognostic Markers in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy. [PDF]

Int J Mol Sci
Kim R, Kin T, Arihiro K.
europepmc   +1 more source

The role of tumor-infiltrating lymphocytes and depth of invasion in T1 bladder cancer: a retrospective analysis. [PDF]

BMC Urol
Yaprak Bayrak B, Dogan HN, Teke K, Yuvak H, Dillioglugil O.   +4 more
europepmc   +1 more source

Decoding tumor-infiltrating lymphocytes heterogeneity in ductal carcinoma in situ: immune microenvironment dynamics and prognostic insights. [PDF]

Discov Oncol
Wang L, Yang Y, Song Y, Zeng J, Zheng H, Wu X.   +5 more
europepmc   +1 more source

Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial. [PDF]

Nat Med
Lowery FJ, Goff SL, Gasmi B, Parkhurst MR, Ratnam NM, Halas HK, Shelton TE, Langhan MM, Bhasin A, Dinerman AJ, Dulemba V, Goldlust IS, Gustafson AM, Hakim AA, Hitscherich KJ, Kenney LM, Levy L, Rault-Wang JG, Bera A, Ray S, Seavey CD, Hoang CD, Hernandez JM, Gartner JJ, Sindiri S, Prickett TD, McIntyre LS, Krishna S, Robbins PF, Klemen ND, Kwong MLM, Yang JC, Rosenberg SA.   +32 more
europepmc   +1 more source

Integrative prognostic model incorporating high mobility group box 1 subcellular localization and tumor-infiltrating lymphocytes in early-stage lung adenocarcinoma. [PDF]

Diagn Pathol
Liu Y, Shimasaki M, Kumagai M, Han J, Shioya A, Sakurai M, Uramoto H, Yamada S.   +7 more
europepmc   +1 more source